GLP-1 Side Effects and When to Get Help

These medicines delay stomach emptying and affect appetite. A meal that used to feel comfortable may now leave you overly full. The degree of nausea, reflux, or bowel change varies with the product and dose. A symptom that prevents normal eating or daily activity deserves a review.

For mild nausea, try smaller portions, eat slowly, and stop when comfortably full. Bland, lower-fat foods may be easier to tolerate, and staying upright after a meal can help. Keep drinking regularly. These adjustments can support comfort; they cannot make severe or persistent symptoms safe to ignore.

If constipation persists, ask the pharmacist or prescriber about a suitable treatment and fluid or fiber advice. Report abdominal swelling, severe pain, vomiting, or inability to pass stool or gas promptly. Do not treat that combination as ordinary constipation.

Tell the clinician the product name, dose, last administration time, and any recent increase. If an incorrect amount was injected or swallowed, get immediate advice from a clinician or poison-control service. FDA has reported hospitalizations after compounded semaglutide dosing errors.

Insulin and sulfonylureas increase the risk of low blood sugar when combined with these medicines. Your diabetes team may need to adjust them. Symptoms can include sweating, shaking, confusion, or palpitations. Follow your agreed hypoglycemia plan, and get emergency help for severe confusion, seizures, or unconsciousness.

People with diabetes-related eye disease should discuss eye monitoring and report vision changes. Rapid improvement in glucose can temporarily worsen retinopathy. Before surgery or deep sedation, tell the team about treatment because food may remain in the stomach despite routine fasting.

Interaction advice is product-specific. Tirzepatide can reduce the effectiveness of oral hormonal contraception: its US label advises a nonoral method or added barrier contraception for four weeks after starting and after each dose increase. A pharmacist should check the full medication list.

• Record when symptoms began relative to the dose or injection.
• Describe how often you vomit, bowel changes, fluid intake, and impact on meals.
• Include other medicines and any possibility of pregnancy.
• Ask whether the increase should be delayed, the dose adjusted, or treatment changed.

Current safety information also matters. On January 13, 2026, FDA requested removal of the suicidal-behavior warning from affected GLP-1 weight-treatment labels after its review found no increased risk. New or worsening mood symptoms still need care on their own merits. Urgent help is needed for suicidal thoughts or immediate danger.